Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Amgen's Repatha Gets NHS Nod, Sanofi's Praluent Misses Out

This article was originally published in Scrip

Executive Summary

Amgen Inc. looks to be in with a chance to push back its biggest rival, partners Sanofi and Regeneron Pharmaceuticals, and strive for dominance of the PCKS9 market space in the UK for patients with high cholesterol.

Advertisement
Advertisement
UsernamePublicRestriction

Register